1. 198 OUTCOME OF AZACITIDINE TREATMENT AND INCIDENCE OF FEBRILE EVENTS IN "REAL WORLD" PATIENTS WITH MDS OR LOW-BLAST COUNT AML. Issue 1 (April 2015) Authors: Voso, M.T.; Niscola, P.; Piciocchi, A.; Fianchi, L.; Maurillo, L.; Musto, P.; Pagano, L.; Mansueto, G.; Criscuolo, M.; Aloe-Spiriti, M.A.; Buccisano, F.; Venditti, A.; Tendas, A.; Piccioni, A.L.; Zini, G.; Latagliata, R.; Filardi, N.; Fragasso, R.; Fenu, S.; Breccia, M. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Erythropoietin levels and erythroid differentiation parameters in patients with lower-risk myelodysplastic syndromes. (August 2018) Authors: Gurnari, C.; Latagliata, R.; Buccisano, F.; Piciocchi, A.; Fenu, S.; Mancini, S.; Fianchi, L.; Criscuolo, M.; Sarlo, C.; Romano, A.; Falconi, G.; Niscola, P.; Di Veroli, A.; Breccia, M.; Piccioni, A.; Aloe-Spiriti, M.A.; Lo-Coco, F.; Voso, M.T. Journal: Leukemia research Issue: Volume 71(2018) Page Start: 89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Management and outcome of 11 pregnancies in women with polycythemia vera. (June 2019) Authors: Elli, E.M.; Diral, E.; Gambacorti-Passerini, C.; Calori, R.; Carmosino, I.; Breccia, M.; Latagliata, R.; Di Veroli, A. Journal: Leukemia research Issue: Volume 81(2019) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MDS-Can-It: A New Validated International ESA-Response Score that Further Refines the Predictive Power of the Nordic Scoring System. (April 2017) Authors: Buckstein, R.; Balleari, E.; Wells, R.A.; Santini, V.; Salvetti, C.; Allione, B.; Danise, P.; Finelli, C.; Clavio, M.; Zhu, N.; Michelle, G.; Sabloff, M.; Leitch, H.; Leber, B.; Luca, M.; Latagliata, R.; Antonietta, M.; Villivà, N.; Piccioni, A.L.; Buccisano, F. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P1011: PREDICTORS OF COVID-19 DISEASE AND SURVIVAL TO COVID-19 IN MPN PATIENTS TREATED WITH RUXOLITINIB. (23rd June 2022) Authors: Palandri, F.; Bartoletti, D.; Elli, E. M.; Auteri, G.; Bonifacio, M.; Benevolo, G.; Heidel, F.; Trawinska, M. M.; Rossi, E.; Bosi, C.; Tieghi, A.; Tiribelli, M.; Iurlo, A.; Polverelli, N.; Caocci, G.; Binotto, G.; Cavazzini, F.; Beggiato, E.; Cilloni, D.; Tatarelli, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 901 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The IPSS-R has prognostic impact in untreated patients with MDS del(5q). (September 2018) Authors: Kaivers, J.; Lauseker, M.; Hildebrandt, B.; Fenaux, P.; Pfeilstöcker, M.; Valent, P.; Platzbecker, U.; Latagliata, R.; Oliva, E.N.; Xicoy, B.; Götze, K.; Ganster, C.; Haase, D.; Bug, G.; Kündgen, A.; Gattermann, N.; Haas, R.; Germing, U. Journal: Leukemia research Issue: Volume 72(2018) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling: THE GENE EXPRESSION PROFILE OF GENES BELONGING TO TRANSFORMING GROWTH FACTOR-B PATHWAY IS DEREGULATED IN SF3B1 MUTATED LOW-RISK MDS PATIENTS. (May 2023) Authors: Fabiani, E.; Hajrullaj, H.; Cristiano, A.; Silvestrini, G.; Galossi, E.; Falconi, G.; Hutter, S.; Nadarajah, N.; Maurillo, L.; Latagliata, R.; Haferlach, T.; Voso, M.T. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗